Reviewing The Case For Salesforce Inc (CRM) Going Higher

Currently, there are 956.00M common shares owned by the public and among those 932.29M shares have been available to trade.

The company’s stock has a 5-day price change of 6.94% and 22.03% over the past three months. CRM shares are trading 3.82% year to date (YTD), with the 12-month market performance up to 25.36% higher. It has a 12-month low price of $212.00 and touched a high of $369.00 over the same period. CRM has an average intraday trading volume of 6.21 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.22%, 2.92%, and 22.19% respectively.

Institutional ownership of Salesforce Inc (NYSE: CRM) shares accounts for 81.65% of the company’s 956.00M shares outstanding.

It has a market capitalization of $332.17B and a beta (3y monthly) value of 1.30. The stock’s trailing 12-month PE ratio is 57.10, while the earnings-per-share (ttm) stands at $6.08. The company has a PEG of 3.60 and a Quick Ratio of 1.01 with the debt-to-equity ratio at 0.21. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.06% over the week and 2.38% over the month.

Earnings per share for the fiscal year are expected to increase by 22.13%, and 11.83% over the next financial year. EPS should shrink at an annualized rate of 15.87% over the next five years, compared to 24.06% over the past 5-year period.

Looking at the support for the CRM, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on January 17, 2025, with the firm’s price target at $380-$400. Guggenheim coverage for the Salesforce Inc (CRM) stock in a research note released on January 06, 2025 offered a Sell rating with a price target of $247. KeyBanc Capital Markets was of a view on December 13, 2024 that the stock is Overweight, while Macquarie gave the stock Neutral rating on December 12, 2024, issuing a price target of $370. BMO Capital Markets on their part issued Outperform rating on December 04, 2024.

Most Popular

Related Posts